Message from the GM:

"Sinensix Pharma, an affiliate of International companies CHEMO and RECALCINE, is committed to bring to Thai patients access to quality imported medicines with large benefits at accessible prices and new therapeutic alternatives to the healthcare professionals with innovative products." The driver in our daily activities and in our development is that the patient, the human being is never forgotten.
 

Business Strategies:

Sinensix Pharma is firmly committed to its objective of being at the forefront in innovation and marketing in the field of women’s health in Thailand. Sinensix Pharma wishes to offer therapeutic solutions at the best cost to support Thai women during all the steps of their life.

As active actor in the new R&D areas, we are aiming as well to propose innovative biotechnology products offering solutions in uncovered or major diseases.

Company profiles

Behind Sinensix Pharma : More Than 4,000 people

  • 14 factories with a recognized industrial know-how
  • a large scope of activities: Active Pharmaceutical Ingredients (API), Finished Dosage Form (FDF)
  • International Presence (EU, Central Latin America, China, USA, South East Asia)
  • Strong Expertise in woman healthcare
  • More than 2,000 products available
  • More than 150 products in R&D
  • Investment (e.g. USA, China and in South-East Asian)

SINENSIX PHARMA IN THAILAND

  • Established in 2007
  • Full product range for women healthcare specialist
  • Original research, own developments, patent products
  • High quality manufacturing products : BE studies in USA / EU
  • International standard products
  • Affordable price and high quality
  • Clinical development in Thailand

CHEMO

  • Founded in 1977 in Spain
  • Present in all sectors of the pharmaceutical industry : trading, generics, both API's and final dosage forms, own branded pharmaceuticals and veterinary products
  • Involved in R+D activity, and highly committed with social
  • 11 industrial plants, 4 R+D specialized centers, 8 commercial offices and 9 joint venture companies in Europe, America and Asia
  • Research, develop and manufacture high quality products for prestigious pharmaceutical companies as well as its own products, and to distribute medicines all over the world.

Website: www.chemogroup.com

Worldwide Presence and Joint Ventures

  • LICONSA
  • LEON FARMA
  •  
  • INDUSTRIALE CHIMICA
  • QUIMIC SINTETICA
  • GOLD PHARMA
  • CHEMO IBERICA MADRID
  • CHEMO IBERICA BARCELONA
  • CHEMO LUGANO BRANCH
  • CHEMO-EAST
  • ROMIKIN
  • CHEM-EAST
 
Joint Ventures management CHEMO :
  • CHEMO IBERICA MADRID
  • CHEMO IBERICA BARCELONA
  • CHEMO LUGANO BRANCH
  • CHEMO-EAST
  • ROMIKIN
  • CHEM-EAST
  • Founded in 1920s in Chile, the first medicine created was calcium and medications that acted as calcium substitutes.
  • In 1940s gained leadership in the introduction of new medicine to the country and then becoming the main penicillin supplier

Website: www.recalcine.cl/

International Expansion
  • Currently present in 16 countries of Latin America, and in 2006 the company enters the Asian country
  • The most modern technology and the high quality standards in Latin America
Pioneers in Bioequivalence and Bioavailability Studies
  • In 2005, the first and only laboratory in the country that maintains permanent studies on Bioavailability and Bioequivalence that assures the efficiency in vivo of its medications
  • Enter other countries and continents, where the quality of its medications has the acknowledgement of the medical world and university
  • MIAMI
  • MEXICO
  • REP.DOMINICANA
  • CENTRO AMERICA
  • HONDURAS
  • PANAMA
  • NICARAGUA
  • SALVADOR
  • GUATENALA
  • COLOMBIA
  • Venezuela
  • ECUADOR
  • PARAGUAY
  • PERU
  • BOLIVIA
  • CHILE
  • ECUADOR
  • ARGENTINA
  • VIETNAM